Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Pain Management Market

Veterinary Pain Management Market Analysis

  • Report ID: GMI5882
  • Published Date: May 2023
  • Report Format: PDF

Veterinary Pain Management Market Analysis

Based on product, the veterinary pain management market is segmented into drugs and devices. Drugs segment accounted for the largest market share in terms of revenue in 2022. .  The veterinary pain management drugs are more widely used and cost-effective. Drugs are able to treat a wide variety of diseases and are more easily available, and also, they are convenient to administer in certain scenarios compared to devices. The drugs are further subsegmented into NSAIDS, opioids, anesthetics, alpha-2 agonists, and other drugs.

Companies are trying to develop new NSAIDs with lesser adverse effects and reactions. For instance, in January 2022, the U.S. FDA approved Zorbium (buprenorphine transdermal solution), the first transdermal buprenorphine animal medication for post-surgical pain management in cats.

By application, the veterinary pain management market is segmented into joint pain, cancer, postoperative pain, and other applications. The joint pain segment accounted for the largest market share in 2022. The large share of this segment can be attributed to increasing prevalence of animal diseases includes osteoarthritis and musculoskeletal disorders. For instance, in 2021, as per the report published by journal of small animal practices, 1 in 5 dogs (20%) experience hip & joint issues at some point in their life. This can result in pain, reduction in mobility and a possible reduction in a dog’s quality of life. Trying to determine dog joint pain or dog mobility issues can be a stressful task for pet parents, which is expected to boost the market upsurge.

Veterinary Pain Management Market Share, By Animal Type, 2022

Based on animal type, the veterinary pain management market is segmented into companion animals and livestock animals. The companion animal segment accounted for the largest revenue share in 2022 owing to increase in their ownership, awareness regarding better pet care, demand for efficient animal care, and high animal healthcare spending in developing countries.

By end-user, the market is segmented into veterinary hospitals, veterinary clinics, retail pharmacies, and online pharmacies. The veterinary hospitals segment dominated the market and accounted for the largest market share of 43.8% in 2022. This is owing to a growing number of veterinary hospitals globally with advanced infrastructures.

Veterinary hospitals are very crucial for veterinary pain management as they provide professional therapies.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary pain management industry size was USD 1.7 billion in 2023 and will witness 7.1% CAGR from 2024-2032 driven by the rising number of pet owners worldwide.

The drug product segment is expected to gain traction through 2032 owing to their rising usage to treat a wide variety of diseases

The veterinary hospitals end-user segment held 43.8% of the veterinary pain management industry share in 2022 due to the ease of access to professional therapies.

Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Norbrook, Ceva Santé Animale, Dechra Pharmaceuticals, Vetoquinol Inc., Alivira Animal Health Limited are some of the key veterinary pain management market players

Veterinary Pain Management Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 591
  • Countries covered: 19
  • Pages: 327
 Download Free Sample